Compare BWMN & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMN | CDXS |
|---|---|---|
| Founded | 1995 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.6M | 256.3M |
| IPO Year | 2021 | 2008 |
| Metric | BWMN | CDXS |
|---|---|---|
| Price | $42.56 | $1.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $45.50 | N/A |
| AVG Volume (30 Days) | 561.0K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 329.41 | 43.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $490,017,000.00 | $138,590,000.00 |
| Revenue This Year | $14.93 | $7.73 |
| Revenue Next Year | $11.57 | $14.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 14.88 | ★ 32.30 |
| 52 Week Low | $25.07 | $0.96 |
| 52 Week High | $45.83 | $2.98 |
| Indicator | BWMN | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 82.90 | 38.53 |
| Support Level | $32.82 | $1.38 |
| Resistance Level | N/A | $1.76 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | -0.48 | -0.00 |
| Stochastic Oscillator | 27.74 | 9.86 |
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.